HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alaa Atamna Selected Research

Hematologic Neoplasms (Hematological Malignancy)

2/2024An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
6/2021The Importance of Abnormal Platelet Count in Patients with Clostridioides difficile Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alaa Atamna Research Topics

Disease

4COVID-19
02/2024 - 01/2021
4Human Influenza (Influenza)
09/2023 - 12/2019
4Infections
10/2022 - 12/2019
4Pneumonia (Pneumonitis)
07/2021 - 12/2019
3Myocarditis (Carditis)
07/2021 - 12/2019
3Encephalitis (Encephalitis, Rasmussen)
07/2021 - 12/2019
2Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 06/2021
2Venous Thromboembolism
11/2023 - 08/2019
2Hypoalbuminemia
06/2021 - 12/2017
1Aspergillosis
02/2024
1Lymphoma (Lymphomas)
02/2024
1Neutropenia
11/2023
1Leukemia
11/2023
1Respiratory Insufficiency (Respiratory Failure)
09/2023
1Hypersensitivity (Allergy)
10/2022
1Invasive Candidiasis
07/2022
1Candidiasis (Moniliasis)
06/2022
1Dementia (Dementias)
03/2022
1Colitis
03/2022
1Urinary Tract Infections (Urinary Tract Infection)
12/2021
1Acute Kidney Injury (Acute Renal Failure)
06/2021
1Thrombocytopenia (Thrombopenia)
06/2021
1Thrombocytosis (Thrombocythemia)
06/2021
1Atrial Fibrillation
01/2021
1Epidemic Louse-Borne Typhus (Typhus)
01/2021
1Candidemia
09/2019
1Neoplasms (Cancer)
08/2019
1Bacteremia
04/2019
1Septic Shock (Toxic Shock Syndrome)
04/2019
1Leukocytosis (Pleocytosis)
10/2017
1Sepsis (Septicemia)
10/2017
1Diabetes Mellitus
10/2017

Drug/Important Bio-Agent (IBA)

3AnticoagulantsIBA
11/2023 - 08/2019
3Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 12/2019
3AlbuminsIBA
03/2022 - 10/2017
1TriazolesIBA
02/2024
1cilgavimabIBA
02/2024
1tixagevimabIBA
02/2024
1obinutuzumabIBA
02/2024
1Rituximab (Mabthera)FDA Link
02/2024
1Monoclonal AntibodiesIBA
02/2024
1FluoroquinolonesIBA
11/2023
1Carbon MonoxideIBA
02/2023
1Sodium Glutamate (Accent)IBA
07/2022
1Serum AlbuminIBA
03/2022
1N-propionyl-L-valine (A 195)IBA
07/2021
1AntibodiesIBA
01/2021
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019
1Cephalosporins (Cephalosporin Antibiotics)IBA
09/2019
1IronIBA
04/2019
1Metronidazole (Metric)FDA LinkGeneric
10/2017
1CreatinineIBA
10/2017

Therapy/Procedure

5Therapeutics
02/2024 - 10/2017
5Artificial Respiration (Mechanical Ventilation)
09/2023 - 12/2019
4Length of Stay
07/2021 - 04/2019
2Drug Therapy (Chemotherapy)
11/2023 - 06/2021
2Activities of Daily Living (ADL)
06/2021 - 10/2017
1Hematopoietic Stem Cell Transplantation
11/2023
1Colectomy
03/2022
1Surgical Amputation (Amputations)
12/2021
1Kidney Transplantation
12/2021
1Personal Protective Equipment
01/2021
1Critical Care (Surgical Intensive Care)
01/2021
1Central Venous Catheters
09/2019
1Duration of Therapy
08/2019